|
Real-time Estimate
Cboe BZX
19:43:14 28/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.045 USD | +0.25% |
|
-8.85% | -43.70% |
| 10-28 | Altimmune, Inc. Announces Board Changes | CI |
| 09-30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALTIMMUNE, INC. | Bio Therapeutic Drugs | +0.21% | -8.85% | -43.70% | -49.94% | -82.01% | 397M |  | | |
- Stock Market
- Stocks
- ALT Stock
- Charts Altimmune, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
